www.taro.com

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

Earnings Release & Call Transcripts

Receive E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!

Earnings Press Releases

Date	Title
Toggle Summary01/24/23	Taro Provides Results for December 31, 2022 HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 24, 2023-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2022 . Quarter ended December 31, 2022 * Highlights ─ compared to December 31,
Toggle Summary10/27/22	Taro Provides Results for September 30, 2022 HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 27, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and six months ended September 30, 2022 . Quarter ended September 30, 2022 * Highlights ─ compared to September
Toggle Summary07/27/22	Taro Provides Results for the Quarter Ended June 30, 2022 HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jul. 27, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2022 . Quarter ended June 30, 2022 * Highlights ─ compared to June 30, 2021 Net sales increased
Toggle Summary05/26/22	Taro Provides Results for the Year Ended March 31, 2022 HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 26, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2022 . Quarter ended March 31, 2022 Highlights ─ compared to March 31, 2021   The quarter
Toggle Summary01/27/22	Taro Provides Results for December 31, 2021 HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 27, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2021 . Quarter ended December 31, 2021 Highlights ─ compared to December 31,
Toggle Summary10/28/21	Taro Provides Results for September 30, 2021 HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 28, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and six months ended September 30, 2021 . Quarter ended September 30, 2021 Highlights ─ compared to September 30,
Toggle Summary07/27/21	Taro Provides Results for Quarter Ended June 30, 2021 HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jul. 27, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) today provided unaudited financial results for the quarter ended June 30, 2021 . Quarter ended June 30, 2021 Highlights - compared to Quarter ended June 30, 2020 Net sales increased $29.5
Toggle Summary05/19/21	Taro Provides Results for the Year Ended March 31, 2021 HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 19, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2021 . Quarter ended March 31, 2021 Highlights ─ compared to March 31, 2020 Net sales of

Call Transcripts

Documents
Add Files Taro Year-End 2019/20 Earnings Call Transcript 84.8 KB
Add Files Taro First Half 2019/20 Earnings Call Transcript 102.7 KB
Add Files Taro Year-End 2018/19 Earnings Call Transcript 112.6 KB

|

Privacy Statement

|

Safe Harbor Statement